Cargando…
Application of Extracorporeal Apheresis in Treatment of COVID-19: a Rapid Review
Spread of a novel coronavirus infection in 2019 caused by SARS-CoV-2 virus has become a real threat to public health all around the world. The new pandemic required the mobilization of all resources for effective treatment of COVID-19 patients. Extracorporeal apheresis methods were suggested as an a...
Autores principales: | Lezhnina, Arina, Lem, Violetta, Blatt, Nataliya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096332/ https://www.ncbi.nlm.nih.gov/pubmed/35578681 http://dx.doi.org/10.1007/s12668-022-00987-x |
Ejemplares similares
-
Current view: indications for extracorporeal lipid apheresis treatment
por: Schettler, Volker, et al.
Publicado: (2012) -
Apheresis and Covid-19
por: Griveas, Ioannis
Publicado: (2022) -
Application of Monoclonal Antibody Drugs in Treatment of COVID-19: a Review
por: Kirillova, Aleksandra, et al.
Publicado: (2022) -
Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis?
por: Bornstein, Stefan R., et al.
Publicado: (2021) -
Clinical improvement of sepsis by extracorporeal centrifugal leukocyte apheresis in a porcine model
por: Zhou, Lei, et al.
Publicado: (2022)